BioRegio STERN Management GmbH is a partner of the EU-funded project "S3martMed", which was launched in early October 2018 and has a term of two years. The goal of the 2-year European initiative and the 5 partners - Biowin (Wallonia), BioPmed (Piedmont), GAPR - Medsilesia (Upper Silesia), BioRegio STERN (Baden Württemberg) and Lyonbiopole (Auvergne-Rhône-Alpes) - is to participate in the implementation of the Smart Specialisation policies with Regions and encourage future investments in medical technologies.
The cluster parners´ ambition is to foster european collaborations of their community and SMEs´ members
The 5 partner clusters of S3martMed are active members of the S3 Industrial Modernisation Platform dedicated to medical technologies launched by the European commission and the Region in 2017. They decided to implement this new project in order to accelerate the emergence of interregional collaborations initiated within the platform, in particular between technology centers and SMEs.
As a first step, the objective is to offer meeting opportunities through the organisation of B2B and Clusters to Clusters networking events, at inter-regional level, involving SMEs, technology centers and key players from partner regions, and beyond. Indeed, all networking activities will be open and shared with the 24 European regions and clusters involved in the S3 Medtech platform. Two partnering events are already scheduled for 2019 and 2020.
In a second step, once the interregional collaborations are identified between the stakeholders, the ambition will be to support these collaborations in their maturation until the definition of investment and financing scenarios and with the regional authorities. The identification of common territorial development strategies and the alignment of practices (for example, evaluation criteria and methodologies, publication schedule of funding calls, etc.) will constitute the "glue" that will enable future multi-regional initiatives.
“The content of this part of the S3martMed project, represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Executive Agency for Small and Medium-sized Enterprises (EASME) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.”